Embera NeuroTherapeutics, Inc. - PRWeb Press Release Account Feed http://www.rsspad.com/rss2a/196162.xml Embera NeuroTherapeutics, Inc. - Press Releases en xml@emediawire.com xml@emediawire.com 30 Embera Initiates Cocaine Addiction Study at LSU Health Sciences Center http://www.prweb.com/releases/2008/01/prweb590551.htm Embera NeuroTherapeutics, Inc. announced the commencement of the first clinical trial evaluating its patent-pending drug combination for the treatment of cocaine addiction. The study is being conducted at the LSU Health Sciences Center's Psychopharmacology Research Clinic in Shreveport under the supervision of Dr. Anita Kablinger. (PRWeb Jan 2, 2008)

Read the full story at http://www.prweb.com/releases/2008/01/prweb590551.htm

]]> http://www.prweb.com/releases/2008/01/prweb590551.htm Embera Scientific Advisory Board is Formed with Distinguished Professors Renowned in Addiction Research http://www.prweb.com/releases/2007/05/prweb527010.htm Charles O'Brien, MD, Phd; Kathleen Brady, MD, PhD and Rajita Sinha, PhD have joined Embera's newly formed Scientific Advisory Board and will lend their expertise to the company as they begin the drug development process for a novel product to treat addiction. (PRWeb May 18, 2007)

Read the full story at http://www.prweb.com/releases/2007/05/prweb527010.htm

]]> http://www.prweb.com/releases/2007/05/prweb527010.htm Embera NeuroTherapeutics, Inc. Closes Series A Funding, Starting FDA Trial Process http://www.prweb.com/releases/2007/02/prweb503068.htm Embera NeuroTherapeutics, Inc., a start-up company developing novel treatments for a broad range of addictions, as well as other neuropsychiatric disorders, has secured over $800,000 of Series A financing that will help the company move its novel combinational drug into Phase 1b FDA trials. (PRWeb Feb 8, 2007)

Read the full story at http://www.prweb.com/releases/2007/02/prweb503068.htm

]]> http://www.prweb.com/releases/2007/02/prweb503068.htm TVP, LP Announces Closing of Venture Capital Fund to Address Diabetes, Nutrition and Obesity Utilizing the Pennington Biomedical Research Center http://www.prweb.com/releases/2006/04/prweb378116.htm The fund manager of Louisiana Ventures, LP, a $25 million venture capital fund organized two years ago, is pleased to announce it has secured the financial commitments necessary to form a venture capital fund that will commercialize technologies from the Pennington Biomedical Research Center. (PRWeb Apr 27, 2006)

Read the full story at http://www.prweb.com/releases/2006/04/prweb378116.htm

]]> http://www.prweb.com/releases/2006/04/prweb378116.htm